Brief: Immunovia Provides Updates On The Price For The IMMray PanCan-D Test In The US

Immunovia AB (publ)

10/08/2021 12:20

Aug 10 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA PROVIDES UPDATES ON THE PRICE FOR THE IMMRAY TM 
PANCAN-D TEST IN THE US AND IMPROVED TEST PERFORMANCE IN THE
FAMILIAL/HEREDITARY RISK GROUP
    * IMMRAY(TM) PANCAN-D TEST IS BEING LAUNCHED AT A LIST PRICE
OF
995 USD PER TEST, WHICH IS HIGHER THAN 600 USD PER TEST
PREVIOUSLY DISCLOSED
    * OVERALL SENSITIVITY OF IMMRAY(TM) PANCAN-D TEST IMPROVES
TO 89%
IN STAGES I AND II AND 92% IN ALL STAGES

Source text for Eikon:  ID:nWkr14gV4h 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))